We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Defers U.S. GMP Inspections Pending November Activation of Mutual Agreement
EMA Defers U.S. GMP Inspections Pending November Activation of Mutual Agreement
The European Medicines Agency is putting off plans for GMP inspections in the U.S. when possible, an EMA spokesperson confirmed this week, in anticipation of the November launch of a mutual agreement between the EU and U.S.